Colis, Algen L.
HRN: 21-45-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2022
CEFUROXIME 750MG (VIAL)
06/07/2022
06/15/2022
IVT
575mg
Q8
Soft Tissue Injury Sec To MVA
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes